LB Pharmaceuticals Inc (LBRX) insider trading

Every open-market stock purchase and sale by LB Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $10M over the last 12 months (1 buy).
  • Last insider buy: Deep Track Biotechnology Master Fund Ltd. (Insider), $8M, 8 months ago.

Last 12 months: insiders bought $10M (1 buy) and sold $0 (0 sales). Last close $28.53 on Jun 4, 2026.

Recent LBRX insider trades

DateInsiderTradeValue
Jun 3, 2026Rekha Hemrajani (Insider)Bought (not open market)—
Jun 3, 2026Ran Nussbaum (Insider)Bought (not open market)—
Jun 3, 2026Robert A. Lenz (Insider)Bought (not open market)—
Jun 3, 2026William P Kane Jr (Insider)Bought (not open market)—
Jun 3, 2026Rebecca Luse (Insider)Bought (not open market)—
Jun 3, 2026Robert R Ruffolo (Insider)Bought (not open market)—
Jun 3, 2026J. Scott Garland (Insider)Bought (not open market)—
Mar 6, 2026Robert A. Lenz (Insider)Bought (not open market)—
Feb 6, 2026Deep Track Biotechnology Master Fund Ltd. (Insider)Bought$8M
Feb 6, 2026Deep Track Biotechnology Master Fund Ltd. (Insider)Bought$2M
Dec 10, 2025Panandiker Kaya Kamlesh Pai (C-suite exec)Bought (not open market)—

Who's trading LBRX

Get free alerts when an insider at LB Pharmaceuticals Inc files a new trade →